Product Categories
| Country: | China |
|---|---|
| Tel: | 020-61855200 |
| Mobile: | +8613326451905 |
| E-mail: | 3004254637@qq.com |
| QQ: | 2881290884 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Moxifloxacin peak discrimination (bedqm cat. No. y0002081) | Details |
| Melphalan lmpurity 6 | C13H16Cl2N2O4 | 1951445-22-9 | Details |
| Melphalan lmpurity 3 | C11H16Cl2N2O2 | 896715-19-8 | Details |
| Melphalan lmpurity 7 | Details |
| Melphalan lmpurity 5 | Details |
| Mupirocin Impurity 6 | C26H44O9 | Details |
| Ceftriaxone impurity 29(ene Isomer) | Details |
| Ticargrelor impurity 7 | C26H32F(18F)N6O4S | 2588537-76-0 | Details |
| Losartan system suitability | Details |
| Chlorpromazine impurity D | Details |
| Betaxolol impurity a | Details |
| Isoproterenol Impurity 27 | Details |
| Mupirocin EP Impurity G | Details |
| Mupirocin EP Impurity H | Details |
| Valsartan Impurity 3 | C24H29N5O3 | Details |
| Benidipine Impurity I | C16H16N2O6 | Details |
| (2-hydroxy-2 - (3-hydroxyphenyl) ethyl) (methyl) amino) - 4-oxobuty-2-enoic acid | Details |
| Bepotastine Impurity 3 | C28H32ClN3O4 | 210095-66-2 | Details |
| Dydrogesterone Impurity 15 | Details |
| N-(2-Quinoxaline)-sulfaquinoxalin. | Details |
| 4-{4-fluoro-3-[(4-nitrosopiperazin-1-yl)carbonyl]benzyl}phthalazin-1(2H)-one | Details |
| Febuxostat Impurity 32 | C12H12N2O | 1805770-41-5 | Details |
| Ticagrelor system suitability for CRS | Details |
| Tranexamic acid impurity F | Details |
| Dydrogesterone Impurity 14 | Details |
| Tranexamic Acid Impurity F CRS（designated brand EP Y0002154） | Details |
| Ceftriaxone sodium impurity H | Details |
| Fosfomycin tromethamine Impurity5(Disodium Salt) | Details |
| Ceftriaxone impurity 30 (olefin isomer disodium salt) | Details |
| 8s-isopropyl-3 β- Mm hydroxymethylammonium bromide | Details |
| 1-nitroso-1H-benzotriazole | Details |
| L-salbutamol impurity B | Details |
| Milbemycin EP impurities I | Details |
| Macitentan Impurity 42 | Details |
| Mupirocin Impurity 5 | C26H44O9 | Details |
| Escitalopram system suitability (assigned brand EDQM cat. No. y0001797) | Details |
| Ketoconazole Impurity 28 | Details |
| Ketoconazole Impurity 29 | C14H18N2O3 | 133345-21-8 | Details |
| Sofosbuvir Impurity 32 | C20H17FO6 | 1157884-58-6 | Details |
| Salicylic acid tablets standard (designated brand: Chinese Academy cat. No: 100103) | Details |
| Lansoprazole impurity II (specified brand: Chinese Academy cat. No: 510047) | Details |
| Carbazochrome Sodium Sulfonate Impurity 30 | Details |
| Relugolix Impurity 15 | Details |
| Drotaverine Impurity 13 | Details |
| Methotrexate EP Impurity G | C28H29N9O6 | 2519848-42-9 | Details |
| Benhexol impurity 14 | Details |
| Ofloxacin impurity E | Details |
| Methotrexate Impurity 26 | Details |
| Estradiol valerate impurity 10 | Details |
| Tranexamic acid impurity standard | Details |
| Fluticasone Furoate Impurity 10 | C22H14 | 11111-34-5 | Details |
| Prednisolone Phosphate USP Impurity E | Details |
| Fluticasone Furoate Impurity 8 | Details |
| Tofatinib Impurity 40 | C13H19N5 | Details |
| Drotaverine Impurity 23 | Details |
| Drotaverine Impurity 26 | Details |
| Drotaverine Impurity 25 | Details |
| Drotaverine Impurity 28 | Details |
| Drotaverine Impurity 27 | Details |
| Avibatan genotoxic Impurity 2 | Details |
| Avibatan genotoxic Impurity 1 | Details |
| Timolol EP Impurity J | Details |
| Avibatan genotoxic Impurity 3 | Details |
| Bumetanide Impurity 25 | Details |
| Cabergoline Impurity 24 | C5H8O2 | 591-87-7 | Details |
| Bumetanide Impurity 26 | Details |
| Bumetanide Impurity 22 | Details |
| Molnupiravir Impurity 16 | C16H22N2O7 | 2346620-53-7 | Details |
| Lurasislone Impurity 18 | C29H36N4O4S | 1807983-62-5 | Details |
| Molnupiravir Impurity 17 | Details |
| Famotidine Impurity 26 | C3H7N3O2S | 95853-46-6 | Details |
| Vitamin B2 impurity 3 | C16H20N2O7 | 64480-68-8 | Details |
| Vitamin B2 impurity 1 | Details |
| Fluticasone Furoate Impurity 9 | Details |
| Benhexol impurity 13 | Details |
| Fusidic Acid EP Impurity B | C31H47NaO6 | Details |
| Siliconized microcrystalline cellulose | Details |
| Nimesulide impurity D (control article) | Details |
| Lilalitine impurity 1 | C22H23N7O2 | Details |
| Salbutamol impurity B (designated brand BP cat. No: 852) | Details |
| Amphotericin B Impurity E | Details |
| Phenylhexol impurity 4 | Details |
| Molnupiravir Impurity 21 | Details |
| Fenoterol system suitability CRS | Details |
| 8s-isopropyl-3β-hydroxytropanium bromide | Details |
| Phenylhexol impurity 8 | C15H19NO | 127865-20-7 | Details |
| Montelukast methanol impurities1 | Details |
| Fluconazole triazole ethyl impurity | Details |
| Bumetanide Impurity 23 | Details |
| Bumetanide Impurity 24 | Details |
| Molnupiravir Impurity 19 | Details |
| Moxonidine adulterant(Impuriy) A | Details |
| Gefitinib Impurity 69 | Details |
| Montelukast dicyclohexylamine | Details |
| Vigabatrin Impurity 18 | Details |
| Omeprazole Related Compound F and G Mixture | Details |
| Ibuprofen Impurity 69(mixture) | Details |
| Vilanterol Impurity 44 | C9H13NO3 | 24085-19-6 | Details |
| Milbemycin EP impurities D | Details |
| Milbemycin EP impurities F | Details |
| Product Total： Product Page： | ||||
| 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 | ||||